Immediate Impact
1 by Nobel laureates 19 hit
Citing Papers
A comprehensive review of immune checkpoint inhibitors for cancer treatment
2024 Hit
Bispecific and multispecific antibodies in oncology: opportunities and challenges
2024 Hit
Works of Maria Anderson being referenced
Randomized Phase II Study of Duligotuzumab (MEHD7945A) vs. Cetuximab in Squamous Cell Carcinoma of the Head and Neck (MEHGAN Study)
2016
A study of MPDL3280A, an engineered PD-L1 antibody in patients with locally advanced or metastatic tumors.
2013